UNSPSC 41142066: Urinary bilirubin and its conjugates (nonquantitative) test system

In this classification, Urinary bilirubin and its conjugates (nonquantitative) test system connotes a device used to measure Urinary bilirubin and its conjugates (nonquantitative) levels. US FDA regulates Urinary bilirubin and its conjugates (nonquantitative) test system under 21 CFR 862.1115 and under FDA product code JJB.

UNSPSC 41142066 Urinary bilirubin and its conjugates (nonquantitative) test system is a Commodity code. State and local governments procure diagnostic test kits and reagents for forensic drug analysis, toxicology screening, and laboratory testing operations under this code, though the recent opportunities show significant activity in specialized chemical reagents and reference materials rather than urinary bilirubin assays per se. The Texas Department of Public Safety, Texas Department of Criminal Justice, Texas Health and Human Services Commission, Pinellas County Forensic Laboratory, and Illinois Department of Financial and Professional Regulation are among recent issuing bodies. Work solicited includes immunalysis reagent kits for substance analysis (cannabinoids, opiates, PCP, amphetamines, and other controlled substances), certified reference drug standards for forensic lab validation and evidentiary sample analysis, DNA screening kits for PCR applications, and mass spectrometry equipment for chemical identification. Pinellas County Forensic Laboratory operates under federal funding from the Paul Coverdell Forensic Sciences Improvement Act Program and requires ISO/IEC 17025:2017 and ISO 17034:2016 accreditation compliance for all reference materials; procurement also incorporates state set-aside preferences (SBE priority in Florida, HUB subcontracting requirements in Texas).

Recent activity concentrates in Texas and Florida. The Texas Department of Public Safety issued an IFB (40526R0008445A) due July 23, 2026, for Direct ELISA testing kits and phosphate-buffered saline solution across 12 line items ranging from 3 to 30 units per item, with anticipated award July 24, 2026. Pinellas County, Florida, posted an Invitation to Quote (26-0305-ITQ) due April 23, 2026, for 131 line items of certified drug standards with 97% minimum purity and five-year records retention funded by $72,126.85 in federal grants, offering SBE preference for quotes submitted within the first five business days. The Texas Health and Human Services Commission issued IFB HHS0016902v2 due January 29, 2026, for QIAxcel and QIAamp DNA screening kits with historical spending between $25,050 and $30,000 annually. Illinois Department of Financial and Professional Regulation established a sole-source joint purchase master contract through ADAPCO, LLC for Response Biomedical's RAMP System mosquito testing equipment (West Nile Virus and Dengue test kits) on May 20, 2026, designed to serve multiple government jurisdictions nationwide.